 Acetazolamide-associated aplastic anaemia Eleven cases acetazolamide-associated aplastic anaemia Sweden period women men median age years years median dose acetazolamide mg median duration treatment months months eleven patients weeks detection aplastic anaemia relative risk aplastic anaemia acetazolamide confidence limits CL estimated incidence acetazolamide-associated aplastic anaemia patient years results acetazolamide treatment substantial increase risk aplastic anaemia